Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Rbms3 | Mouse | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of RBMS3 mRNA | CTD | PMID:28960355 | Rbms3 | Mouse | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of RBMS3 mRNA | CTD | PMID:22206623 | Rbms3 | Mouse | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of RBMS3 mRNA | CTD | PMID:17555576 | Rbms3 | Mouse | 17beta-estradiol | affects expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Estradiol affects the expression of RBMS3 mRNA | CTD | PMID:22574217 | Rbms3 | Mouse | 17beta-estradiol | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of RBMS3 mRNA | CTD | PMID:20660070 | Rbms3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RBMS3 mRNA | CTD | PMID:32109520 | Rbms3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RBMS3 mRNA | CTD | PMID:33387578 | Rbms3 | Mouse | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | Rbms3 | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:38648751 | Rbms3 | Mouse | 2-butoxyethanol | decreases expression | EXP | | 6480464 | n-butoxyethanol results in decreased expression of RBMS3 mRNA | CTD | PMID:19812364 | Rbms3 | Mouse | 2-methylcholine | affects expression | ISO | RBMS3 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of RBMS3 mRNA | CTD | PMID:21179406 | Rbms3 | Mouse | 3',5'-cyclic UMP | affects binding | ISO | RBMS3 (Homo sapiens) | 6480464 | RBMS3 protein binds to cyclic 3' and 5'-uridine monophosphate | CTD | PMID:30528433 | Rbms3 | Mouse | 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of RBMS3 mRNA | CTD | PMID:20713471 | Rbms3 | Mouse | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of RBMS3 gene | CTD | PMID:31601247 | Rbms3 | Mouse | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of RBMS3 mRNA | CTD | PMID:28973697 | Rbms3 | Mouse | 6-propyl-2-thiouracil | increases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of RBMS3 mRNA | CTD | PMID:24780913 | Rbms3 | Mouse | 8-Br-cAMP | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RBMS3 mRNA | CTD | PMID:22079614 | Rbms3 | Mouse | aflatoxin B1 | increases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of RBMS3 intron | CTD | PMID:30157460 | Rbms3 | Mouse | Aflatoxin B2 alpha | increases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of RBMS3 intron | CTD | PMID:30157460 | Rbms3 | Mouse | all-trans-retinoic acid | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RBMS3 mRNA | CTD | PMID:21934132 and PMID:23724009 | Rbms3 | Mouse | alpha-Zearalanol | multiple interactions | ISO | Rbms3 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RBMS3 mRNA | CTD | PMID:35163327 | Rbms3 | Mouse | antirheumatic drug | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of RBMS3 mRNA | CTD | PMID:24449571 | Rbms3 | Mouse | aristolochic acid A | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RBMS3 mRNA | CTD | PMID:33212167 | Rbms3 | Mouse | atrazine | affects methylation | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of RBMS3 gene | CTD | PMID:28931070 and PMID:35440735 | Rbms3 | Mouse | auranofin | affects response to substance | ISO | RBMS3 (Homo sapiens) | 6480464 | RBMS3 protein affects the susceptibility to Auranofin | CTD | PMID:36414028 | Rbms3 | Mouse | benzo[a]pyrene | increases mutagenesis | ISO | RBMS3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of RBMS3 gene | CTD | PMID:25435355 | Rbms3 | Mouse | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of RBMS3 intron | CTD | PMID:27901495 | Rbms3 | Mouse | benzo[a]pyrene | affects methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of RBMS3 intron | CTD | PMID:30157460 | Rbms3 | Mouse | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of RBMS3 mRNA | CTD | PMID:20713471 | Rbms3 | Mouse | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | Rbms3 | Mouse | bisphenol A | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RBMS3 mRNA | CTD | PMID:22576693 | Rbms3 | Mouse | bisphenol A | decreases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of RBMS3 gene | CTD | PMID:31601247 | Rbms3 | Mouse | bisphenol A | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RBMS3 gene | CTD | PMID:31601247 | Rbms3 | Mouse | bisphenol A | decreases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of RBMS3 mRNA | CTD | PMID:25181051 | Rbms3 | Mouse | bisphenol A | increases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of RBMS3 gene | CTD | PMID:22576693 | Rbms3 | Mouse | butanal | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of RBMS3 mRNA | CTD | PMID:26079696 | Rbms3 | Mouse | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | Rbms3 | Mouse | CGP 52608 | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RBMS3 gene] | CTD | PMID:28238834 | Rbms3 | Mouse | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RBMS3 mRNA | CTD | PMID:20938992 | Rbms3 | Mouse | chromium(6+) | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of RBMS3 mRNA | CTD | PMID:38479592 | Rbms3 | Mouse | cisplatin | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of RBMS3 mRNA | CTD | PMID:27392435 | Rbms3 | Mouse | cisplatin | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of RBMS3 mRNA | CTD | PMID:27392435 | Rbms3 | Mouse | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of RBMS3 mRNA | CTD | PMID:29279043 | Rbms3 | Mouse | Cuprizon | increases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of RBMS3 mRNA | CTD | PMID:26577399 | Rbms3 | Mouse | cyclosporin A | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of RBMS3 mRNA | CTD | PMID:20106945 | Rbms3 | Mouse | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of RBMS3 mRNA | CTD | PMID:22733784 | Rbms3 | Mouse | diuron | decreases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of RBMS3 mRNA | CTD | PMID:21551480 | Rbms3 | Mouse | dorsomorphin | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Rbms3 | Mouse | doxorubicin | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of RBMS3 mRNA | CTD | PMID:29803840 | Rbms3 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RBMS3 mRNA | CTD | PMID:20938992 | Rbms3 | Mouse | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of RBMS3 mRNA | CTD | PMID:25629700 | Rbms3 | Mouse | fulvestrant | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RBMS3 gene | CTD | PMID:31601247 | Rbms3 | Mouse | geldanamycin | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of RBMS3 mRNA | CTD | PMID:26705709 | Rbms3 | Mouse | gentamycin | increases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of RBMS3 mRNA | CTD | PMID:33387578 | Rbms3 | Mouse | glyphosate | affects methylation | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Glyphosate affects the methylation of RBMS3 gene | CTD | PMID:35440735 | Rbms3 | Mouse | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RBMS3 mRNA | CTD | PMID:20938992 | Rbms3 | Mouse | mercury dibromide | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of RBMS3 mRNA | CTD | PMID:26272509 | Rbms3 | Mouse | mercury dibromide | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA | CTD | PMID:27188386 | Rbms3 | Mouse | N,N-diethyl-m-toluamide | multiple interactions | ISO | Rbms3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of RBMS3 gene and [Permethrin co-treated with DEET] results in increased methylation of RBMS3 gene | CTD | PMID:33148267 | Rbms3 | Mouse | nickel atom | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of RBMS3 mRNA | CTD | PMID:25583101 | Rbms3 | Mouse | nickel sulfate | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of RBMS3 mRNA | CTD | PMID:22714537 | Rbms3 | Mouse | oxaliplatin | multiple interactions | ISO | Rbms3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of RBMS3 mRNA | CTD | PMID:25729387 | Rbms3 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RBMS3 mRNA | CTD | PMID:34911549 | Rbms3 | Mouse | panobinostat | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA | CTD | PMID:27188386 | Rbms3 | Mouse | paracetamol | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of RBMS3 mRNA | CTD | PMID:29067470 | Rbms3 | Mouse | paracetamol | decreases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of RBMS3 mRNA | CTD | PMID:33387578 | Rbms3 | Mouse | perfluorohexanesulfonic acid | increases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in increased expression of RBMS3 mRNA | CTD | PMID:37995155 | Rbms3 | Mouse | perfluorooctanoic acid | multiple interactions | ISO | Rbms3 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RBMS3 mRNA | CTD | PMID:35163327 | Rbms3 | Mouse | permethrin | multiple interactions | ISO | Rbms3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of RBMS3 gene and [Permethrin co-treated with DEET] results in increased methylation of RBMS3 gene | CTD | PMID:33148267 | Rbms3 | Mouse | phenylmercury acetate | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of RBMS3 mRNA | CTD | PMID:26272509 | Rbms3 | Mouse | phenylmercury acetate | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA | CTD | PMID:27188386 | Rbms3 | Mouse | potassium chromate | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of RBMS3 mRNA | CTD | PMID:22714537 | Rbms3 | Mouse | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of RBMS3 mRNA | CTD | PMID:23608068 | Rbms3 | Mouse | progesterone | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of RBMS3 mRNA | CTD | PMID:20660070 | Rbms3 | Mouse | propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of RBMS3 mRNA | CTD | PMID:21278054 | Rbms3 | Mouse | SB 431542 | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Rbms3 | Mouse | silver atom | decreases expression | EXP | | 6480464 | Silver results in decreased expression of RBMS3 mRNA | CTD | PMID:27131904 | Rbms3 | Mouse | silver(0) | decreases expression | EXP | | 6480464 | Silver results in decreased expression of RBMS3 mRNA | CTD | PMID:27131904 | Rbms3 | Mouse | sodium arsenite | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RBMS3 mRNA | CTD | PMID:22714537 more ... | Rbms3 | Mouse | sulforaphane | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of RBMS3 mRNA | CTD | PMID:31838189 | Rbms3 | Mouse | sunitinib | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of RBMS3 mRNA | CTD | PMID:31533062 | Rbms3 | Mouse | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of RBMS3 mRNA | CTD | PMID:17555576 | Rbms3 | Mouse | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of RBMS3 mRNA | CTD | PMID:17484886 | Rbms3 | Mouse | thiram | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Thiram results in decreased expression of RBMS3 mRNA | CTD | PMID:38568856 | Rbms3 | Mouse | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of RBMS3 mRNA | CTD | PMID:29264374 | Rbms3 | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of RBMS3 mRNA | CTD | PMID:35295148 | Rbms3 | Mouse | topotecan | multiple interactions | ISO | Rbms3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of RBMS3 mRNA | CTD | PMID:25729387 | Rbms3 | Mouse | topotecan | increases expression | ISO | Rbms3 (Rattus norvegicus) | 6480464 | Topotecan results in increased expression of RBMS3 mRNA | CTD | PMID:25729387 | Rbms3 | Mouse | trichostatin A | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA | CTD | PMID:27188386 | Rbms3 | Mouse | trichostatin A | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of RBMS3 mRNA | CTD | PMID:24935251 more ... | Rbms3 | Mouse | triclosan | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of RBMS3 mRNA | CTD | PMID:30510588 | Rbms3 | Mouse | trimellitic anhydride | decreases expression | EXP | | 6480464 | trimellitic anhydride results in decreased expression of RBMS3 mRNA | CTD | PMID:19042947 | Rbms3 | Mouse | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of RBMS3 mRNA | CTD | PMID:28973697 | Rbms3 | Mouse | valproic acid | affects expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RBMS3 mRNA | CTD | PMID:25979313 | Rbms3 | Mouse | valproic acid | decreases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of RBMS3 gene | CTD | PMID:29154799 | Rbms3 | Mouse | valproic acid | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA | CTD | PMID:27188386 | Rbms3 | Mouse | valproic acid | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of RBMS3 mRNA | CTD | PMID:23179753 more ... | Rbms3 | Mouse | vinclozolin | decreases methylation | ISO | Rbms3 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased methylation of RBMS3 gene | CTD | PMID:31079544 | Rbms3 | Mouse | vorinostat | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA | CTD | PMID:27188386 | Rbms3 | Mouse | vorinostat | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | vorinostat results in increased expression of RBMS3 mRNA | CTD | PMID:26272509 and PMID:27188386 | |
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
